Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

mcr-3.1 found in US human patient
Salmonella enterica is responsible for a significant percentage of human illnesses in the US.
Gene allows Salmonella to become resistant to colistin 

Scientists have found a gene that allows Salmonella to become resistant to last resort antibiotics in a human patient in the US.

The discovery provides the first evidence that the gene, mcr-3.1, has made its way to the US from Asia.

Salmonella enterica is responsible for a significant percentage of human illnesses in the US. mcr-3.1 confers resistance to colistin, the drug of last resort for treating multi-drug-resistant infections.

“Public health officials have known about this gene for some time,” said Siddhartha Thakur, director of global health at North Carolina State University. “In 2015, they saw that mcr-3.1 had moved from a chromosome to a plasmid in China, which paves the way for the gene to be transmitted between organisms.

“For example, E. coli and Salmonella are in the same family, so once the gene is on a plasmid, that plasmid could move between the bacteria and they could transmit this gene to each other. Once mcr-3.1 jumped to the plasmid, it spread to 30 different countries, although not – as far as we knew – to the U.S.”  

Professor Thakur’s lab is one of several US labs that is participating in surveillance for resistant strains of Salmonella. Veterinary medicine student Valerie Nelson and PhD student Daniel Monte did genome sequencing on 100 clinical human stool samples from the southeastern US between 2014 and 2016.

One sample was found to contain the resistant mcr-3.1 gene. The patient had travelled to China two weeks prior to becoming ill with a Salmonella infection.

Prof Thakur added: “The positive sample was from 2014, so this discovery definitely has implications for the spread of colistin-resistant Salmonella in the US. Our lab will continue to try and fill in these knowledge gaps.”

The research has been published in the Journal of Medical Microbiology.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.